TRACEY SHAFFER: Open Payments
NPI 1598137564 · THOMSON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,068 in 111 payments from 21 companies in 2025. Trend: 2023 $2,672 · 2024 $3,836 · 2025 $3,068
Food & beverage: $2,789Education: $279
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $454 |
| Incyte Corporation | 10 | $378 |
| UCB, Inc. | 12 | $272 |
| Organon LLC | 4 | $257 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $254 |
| Amgen Inc. | 13 | $246 |
| PFIZER INC. | 7 | $161 |
| Galderma Laboratories, L.P. | 4 | $157 |
| LEO Pharma Inc. | 4 | $154 |
| GENZYME CORPORATION | 8 | $154 |
Products named: TREMFYA, OPZELURA, Bimzelx, OTEZLA, VTAMA, DUPIXENT, NEMLUVIO, ILUMYA.
Industry payments across GA — which companies pay providers there.
